Hoffmann-La Roche AG has published details on <i>the mechanism of action of its Phase I antibiotic Zosurabalpin</i> (RG6006) that kills the carbapenem-resistant bug<i> Acinetobacter baumannii</i>. <br />.
Following its announcement from Oktober 2023 to take over the filgotinib business from Galapagos NV, Bologna-based Alfasigma SpA has signed the €170m deal. <div title="Page 1" class="page"><div class="layoutArea"><div class="column"></div></div></div>
Pharmaceutical giant AstrazZeneca wants to take over the Chinese company Gracell Biotechnologies in order to strengthen its cell therapy projects in a deal worth up to $1.2bn.
Cambridge-based Metrion Biosciences Ltd has secured £3.5m in new equity financing – led by Maven Capital Partners and a £1m contribution from existing investor, Gresham House Ventures.
Swiss LimmaTech Biologics and AbVacc Inc have agreed to co-develop AbVacc’s preclinical <i>Staphylococcus aureus vaccine </i><span style="caret-color: rgb(33, 33, 33); color: rgb(33, 33, 33); font-family: Arial, sans-serif; font-size: 13.333333015441895px; font-style: […]
The French Republicans have tabled a bill in the National Assembly aimed at banning the commercialisation of cell-based meat in France.
Lausanne-based Vandria SA has cashed in CHF18m in a Series A financing led by ND Capital to drive clinical development of VNA-318.
Lausanne-based Vandria SA has cashed in CHF18m in a Series A financing led by ND Capital to drive clinical development of VNA-318.
<a title="http://www.b3cnewswire.com/PRT/link.php?click=1619-2-24039-8B20BDBA70E6BDF1B5F7FEECBC3EA611CB7D4F450000" target="_blank" rel="nofollow noopener" href="http://www.b3cnewswire.com/PRT/link.php?click=1619-2-24039-8B20BDBA70E6BDF1B5F7FEECBC3EA611CB7D4F450000">Antibiotics specialist Antabio SAS</a> has raised €25m in a Series B financing round with subscriptions from the AMR Action Fund, the EIC Fund and from […]
Scientists led by Heiko Rischer from the Finnish research centre VTT have published the proof of concept for cell-based coffee production.